Botulinum Toxin-A

DRUG6 trials

Sponsors

University of British Columbia, Massachusetts General Hospital, University of Manitoba, University of Alabama at Birmingham, Assiut University

Conditions

Breast DiseasesBreast NeoplasmsChronic MigraineFacial PainNeoplasmsNeoplasms by SiteObstructed Defecation Syndrome (ODS)Overactive Bladder

Phase 2

Effects of Botox in Obstructed Defecation Syndrome

TerminatedNCT02160288

Massachusetts General HospitalObstructed Defecation Syndrome (ODS)

Start: 2016-02-29End: 2019-06-11Updated: 2020-05-12

Phase 4

The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction

University of British ColumbiaBreast Diseases, Breast Neoplasms, Neoplasms +2

Start: 2011-10-31End: 2017-12-31Target: 128Updated: 2016-07-29

Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes.

CompletedNCT02436499

University of ManitobaChronic Migraine

Start: 2015-07-31End: 2017-03-31Updated: 2017-09-15

Botox Versus Tacrolimus in Psoriasis Vulgaris

Not yet recruitingNCT06203470

Assiut UniversityPsoriasis Vulgaris

Start: 2024-06-30End: 2026-10-31Target: 60Updated: 2024-06-12

Unknown Phase

Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder

TerminatedNCT02995967

University of Alabama at BirminghamOveractive Bladder

Start: 2016-11-30End: 2017-12-31Updated: 2019-03-13

Arthrocentesis Versus Botulinum Toxin Injection in Patients With Temporomandibular Joint Disorders: A Randomized Controlled Trial

Not yet recruitingNCT07736521

Mudher MB AlsunbuliFacial Pain, Temporomandibular Joint Disorders, Temporomandibular Joint Dysfunction Syndrome

Start: 2026-08-15End: 2027-05-01Target: 66Updated: 2026-07-30